Companies: 10,795·Total market cap: $144.5T
CareDx, Inc

CareDx, Inc

CDNANASDAQHealthcare● Active
$21.95
$-0.30(-1.35%)
Market Cap$1.1B
P/E Ratio
52W High$23.24
52W Low$10.96
Overview

CareDx, Inc (CDNA) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

cdna · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 13 Wall Street analysts in the past 3 months

SellBuy

Buy

13 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
10
Hold
3
Sell
0
Strong Sell
0
Total: 13 · Buy rate: 76.9%

12-Month Price Target

High

$28.00

Consensus

$24.00

+9.3% upside

Low

$18.00

Median: $26 · Last Close: $21.95

The CareDx, Inc (CDNA) analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month CDNA price target is $24.00, representing +9.3% upside from the current price of $21.95.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $24 (9.3%)

Consensus Target

$24.00

9.3% upside

High Target

$28

27.6%

Low Target

$18

-18.0%

Current Price

$21.95

as of today

Based on analyst price targets, the CDNA stock price prediction for the next 12 months ranges from $18 to $28. The consensus CDNA price forecast of $24.00 implies 9.3% upside from the current price of $21.95.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$22.562.76%

1-day model range: $22.46–$22.65. Peak: $22.65 (+2.76%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$30+35.8%
2028$36+62.6%
2029$40+80.2%
2030$42+91.0%
2031+97.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

64%7%29%
9Buy
1Neutral
4Sell
RSI (14)62.4Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · CDNA · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$22.34SELL
MA 10$22.37SELL
MA 20$21.66BUY
MA 50$20.37BUY
MA 100$19.71BUY
MA 200$17.92BUY
Current $CDNA · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$22.30SELL
EMA 10$22.20SELL
EMA 20$21.81BUY
EMA 50$20.80BUY
EMA 100$19.83BUY
EMA 200$18.93BUY
Current $CDNA · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
BTIG2026-04-29
Maintains
BuyBuy
BTIG2026-02-26
Maintains
BuyBuy
Wells Fargo2026-02-25
Maintains
Equal WeightEqual Weight
Wells Fargo2025-12-15
Maintains
Equal WeightEqual Weight
BTIG2025-11-06
Maintains
BuyBuy
BTIG2025-09-23
Maintains
BuyBuy
BTIG2025-09-12
Maintains
BuyBuy
Wells Fargo2025-08-08
Maintains
Equal WeightEqual Weight
Craig-Hallum2025-07-18
Maintains
BuyBuy
Stephens & Co.2025-05-05
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on CareDx, Inc (CDNA) stock. Of the recent 82 rating actions, 8 were upgrades and 6 were downgrades. 13 analysts currently cover CDNA.

Analyst Recommendation Trends

Buy ratings01↑ +1
Hold ratings101
Sell ratings00

CDNA analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$331M

↓ 27.3% YoY

Revenue Next Year

$375M

↑ 13.1% YoY

EPS This Year

$-0.90

EPS Next Year

$-0.30

↓ 66.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CDNA EPS of $-0.90 for the current fiscal year, based on estimates from 4 analysts. The CDNA revenue forecast is $331M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CDNA stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CDNA price target is $24.00 (+9.3% upside), with an analyst consensus of Buy.

The CDNA short-term stock prediction for tomorrow is $22.56 (+2.76%). The CDNA stock price prediction for 2027 estimates an average of $30. The CDNA stock prediction for 2030 projects a range of $40–$44.

CareDx, Inc trades on NASDAQ under the ticker CDNA. The CDNA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 77% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

CDNA forecast · 8 questions

According to 13 Wall Street analysts, the average 12-month CDNA price target is $24.00, with a high forecast of $28.00 and a low of $18.00. The median price target is shown in the chart above when available. This implies +9.3% potential upside from the current price of $21.95.

CDNA price targetWhat is CDNA price targetCDNA analyst price targetCDNA 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.